Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Fomepizole
Drug ID BADD_D00956
Description Fomepizole is used as an antidote in confirmed or suspected methanol or ethylene glycol poisoning. Fomepizole is a competitive inhibitor of alcohol dehydrogenase, the enzyme that catalyzes the initial steps in the metabolism of ethylene glycol and methanol to their toxic metabolites.
Indications and Usage Antizol is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis
Marketing Status Prescription; Discontinued
ATC Code V03AB34
DrugBank ID DB01213
KEGG ID D00707
MeSH ID D000077604
PubChem ID 3406
TTD Drug ID D02NJA
NDC Product Code 67457-211; 0517-0710; 70710-1478; 65732-702; 76339-106; 43744-152; 72969-030; 50384-0600; 14096-107; 68475-510
Synonyms Fomepizole | 4-Methylpyrazole | 4 Methylpyrazole | Antizol | 4-Methylpyrazole Monohydrochloride | 4 Methylpyrazole Monohydrochloride
Chemical Information
Molecular Formula C4H6N2
CAS Registry Number 7554-65-6
SMILES CC1=CNN=C1
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Parosmia17.04.04.002; 22.04.03.007--Not Available
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Phlebitis24.05.03.001; 12.02.01.002--
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Seizure17.12.03.001--
Shock24.06.02.002--Not Available
Sinus bradycardia02.03.03.009--
Somnolence19.02.05.003; 17.02.04.006--
Speech disorder19.19.02.002; 17.02.08.003; 22.02.05.034--Not Available
Tachycardia02.03.02.007--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Vertigo17.02.12.002; 04.04.01.003--
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.06.008--Not Available
Vomiting07.01.07.003--
Phlebosclerosis24.04.02.003--Not Available
Transaminases increased13.03.01.015--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Erectile dysfunction21.03.01.007; 19.08.04.001--
Multiple organ dysfunction syndrome08.01.03.057--
The 2th Page    First    Pre   2    Total 2 Pages